Plasma leptin levels correlate to islet function independently of body fat in postmenopausal women

Diabetes

Volumn 45, Issue 11, 1996, Pages 1580-1584

  Larsson, Hillevi ^a   Elmståhl, Sölve ^a   Ahrén, Bo ^a  

^a LUND UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE; GENE PRODUCT; NEUTRAL INSULIN; PROTEIN;

ADULT; ARTICLE; BODY FAT; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE INFUSION; HUMAN; IMPAIRED GLUCOSE TOLERANCE; INSULIN INFUSION; INSULIN RELEASE; INSULIN SENSITIVITY; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; PANCREAS ISLET CELL FUNCTION; POSTMENOPAUSE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RADIOIMMUNOASSAY;

EID: 0029909389     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diab.45.11.1580     Document Type: Article

References (30)

1. Halaas JL, Gajiwala KS, Maffei M, Cohen SL, Rabinowitz D, Lallone RL, Burley SK, Friedman JM: Weight-reducing effects of the plasma protein encoded by the obese gene. Science 269:543-546, 1995
2. Considine RV, Considine EL, Williams CJ, Nyce MR, Magosin SA, Bauer TL, Rosato EL, Colberg J, Caro JF: Evidence against either a premature stop codon or the absence of obese gene mRNA in human obesity. J Clin Invest 95:2986-2988, 1995
3. Masazuki H, Ogawa Y, Isse N, Satoh N, Okazaki T, Shigemoto M, Mori K, Tamura N, Hosada K, Yoshimasa Y, Jingami H, Kawada T, Nakao K: Human obese gene expression: adipocyte-specific expression and regional differences in the adipose tissue. Diabetes 44:855-858, 1995
4. Maffei M, Halaas J, Ravussin E, Pratley RE, Lee GH, Zhang Y, Fei H, Kim S, Lallone R, Ranganathan S, Kern PA, Friedman JM: Leptin levels in human and rodent: measurement of plasma leptin and ob mRNA in obese and weight-reduced subjects. Nature Med 1:1155-1161, 1995
5. Frederich RC, Hamann A, Andersson S, Löllmann B, Lowell BB, Flier JS: Leptin levels reflect body lipid content in mice: evidence for diet-induced resistance to leptin action. Nature Med 1:1311-1314, 1995
6. Lönnqvist F, Arner P, Nordfors L, Schalling M: Overexpression of the obese (ob) gene in adipose tissue of human obese subjects. Nature Med 1:950-953, 1995
7. Considine RV, Sinha MK, Heiman ML, Kriauciunas A, Stephens TW, Nyce MR, Ohannesian JP, Marco CC, McKee LJ, Bauer TL, Caro JF: Serum immunoreactive-leptin concentrations in normal-weight and obese humans. N Engl J Med 334:292-295, 1996
8. Campfield LA, Smith FJ, Guisez Y, Devos R, Burn P: Recombinant mouse OB protein: evidence for a peripheral signal linking adiposity and central neural networks. Science 269:546-549, 1995
9. Pelleymounter MA, Cullen MJ, Baker MB, Hecht R, Winters D, Boone T, Collins F: Effects of the obese gene product on body weight regulation in ob/ob mice. Science 269:540-543, 1995
10. Lindpaintner K: Clinical implications of basic research: finding an obesity gene - A tale of mice and man. N Engl J Med 322:679-680, 1995
11. Bergman RN, Phillips LS, Cobelli C: Physiologic evaluation of factors controlling glucose tolerance in man: measurement of insulin sensitivity and β-cell glucose sensitivity from the response to intravenous glucose. J Clin Invest 68:1456-1467, 1981
12. Olefsky M, Kolterman OG, Scarlet JA: Insulin action and resistance in obesity and non-insulin dependent type II diabetes mellitus. Am J Physiol 243:E15-E30, 1982
13. Zunigo-Guajardo S, Jimenez J, Angel A, Zinman B: Effects of massive obesity on insulin sensitivity and insulin clearance and the metabolic response to insulin as assessed by the euglycemic clamp technique. Metabolism 35:278-282, 1986
14. Beard JC, Halter JB, Best JD, Pfeifer MA, Porte D Jr: Dexamethasone-induced insulin resistance enhances B cell responsiveness to glucose level in normal men. Am J Physiol 247: E592-E596, 1984
15. Kahn SE, Beard JC, Schwartz MW, Ward WK, Ding HL, Bergman RN, Taborsky GJ Jr, Porte D Jr: Increased β-cell secretory capacity as mechanism for islet adaptation to nicotinic acid-induced insulin resistance. Diabetes 38:562-568, 1989
16. Larsson H, Ahrén B: Failure to adequately adapt reduced insulin sensitivity with increased insulin secretion in women with impaired glucose tolerance. Diabetologia 39:1099-1107, 1996
17. DeFronzo RA, Tobin JD, Andres R: Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol 237:E214-223, 1979
18. Ward WK, Bolgiano DC, McKnight B, Halter JB, Porte D Jr: Diminished B cell secretory capacity in patients with non-insulin-dependent diabetes mellitus. J Clin Invest 74:1318-1328, 1984
19. Larsson H, Ahrén B, Lindgärde F, Berglund G: Fasting blood glucose in determining prevalence of diabetes in a large, homogenous population of Caucasian middle-aged women. J Intern Med 237:537-541, 1995
20. Lukaski HC, Johnson PE, Bolonchuk WW, Lykken GI: Assessment of fat-free mass using bioelectrical impedance measurements of the human body. Am J Clin Nutr 41:810-817, 1985
21. Steen B, Bosaeus I, Elmståhl S, Galvard H, Isaksson B, Robertsson E: Body composition in the elderly estimated with an electrical impedance method. Compr Gerontol A 1:102-105, 1987
22. Elmståhl S, Petersson M, Lilja B, Samuelsson SM, Rosén J, Bjurö L: Body composition in patients with Alzheimer's disease and healthy controls. J Clin Exp Gerontol 14:17-31, 1992
23. Larsson H, Ahrén B: Altered glucose modulation of islet function in obese women with impaired glucose tolerance. Metabolism 45:502-509, 1996
24. Saladin R, De Vos P, Guerre-Millo M, Leturque A, Girard J, Staels B, Auwerx J: Transient increase in obese gene expression after food intake or insulin administration. Nature 377:527-529, 1995
25. Cusin I, Sainsbury A, Doyle P, Rohner-Jeanrenaud F, Jeanrenaud B: The ob gene and insulin: a relationship leading to clues to the understanding of obesity. Diabetes 44:1467-1470, 1995
26. Sainsbury A, Cusin I, Doyle P, Rohner-Jeanrenaud F, Jeanrenaud B: Intracerebral administration of neuropeptide Y to normal rats increases obese gene expression in white adipose tissue. Diabetologia 39:353-356, 1996
27. Larsson H, Berglund G, Ahrén B: Glucose modulation of insulin and glucagon secretion is altered in impaired glucose tolerance. J Clin Endocrinol Metab 80:1778-1782, 1995
28. King H, Zimmet P, Raper LR, Balkan B: The natural history of impaired glucose tolerance in the Micronesian population of Nauru: a six-year follow up study. Diabetologia 26:39-43, 1984
29. Saad MF, Knowler WC, Pettitt DJ, Nelson RG, Mott DM, Bennett PH: The natural history of impaired glucose tolerance in the Pima Indians. N Engl J Med 319:1500-1506, 1988
30. Keen H, Jarrett RJ, McCartney P: The ten-year follow-up of the Bedford survey (1962-1972): glucose tolerance and diabetes. Diabetologia 22:73-78, 1982